ASLAN Pharmaceuticals Ltd (ASLN)
0.4153
-0.03
(-7.30%)
USD |
NASDAQ |
Apr 26, 16:00
0.4469
+0.03
(+7.61%)
After-Hours: 20:00
ASLAN Pharmaceuticals Debt to Equity Ratio
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2023 | 5.942 |
| March 31, 2023 | 3.821 |
| December 31, 2022 | 4.472 |
| September 30, 2022 | 1.648 |
| June 30, 2022 | 1.115 |
| March 31, 2022 | 0.8079 |
| December 31, 2021 | 0.5385 |
| September 30, 2021 | 0.4549 |
| June 30, 2021 | 0.2019 |
| March 31, 2021 | 0.1861 |
| December 31, 2020 | -1.789 |
| September 30, 2020 | -1.503 |
| June 30, 2020 | -2.024 |
| March 31, 2020 | -3.634 |
| Date | Value |
|---|---|
| December 31, 2019 | -10.51 |
| September 30, 2019 | 1.074 |
| June 30, 2019 | 0.775 |
| March 31, 2019 | |
| December 31, 2018 | 0.4564 |
| September 30, 2018 | 0.2344 |
| June 30, 2018 | 0.1838 |
| March 31, 2018 | 0.3705 |
| December 31, 2017 | 0.2726 |
| September 30, 2017 | 0.1841 |
| June 30, 2017 | 0.155 |
| March 31, 2017 | 0.2591 |
| December 31, 2016 | 0.2005 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
-10.51
Minimum
Dec 2019
5.942
Maximum
Jun 2023
0.0926
Average
0.5385
Median
Dec 2021
Debt to Equity Ratio Benchmarks
| Dr Reddy's Laboratories Ltd | 0.0603 |
| Concord Medical Services Holdings Ltd | -1.440 |
| WAVE Life Sciences Ltd | 0.00 |
| BeiGene Ltd | 0.2505 |
| CytoMed Therapeutics Ltd | -- |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 24.63M |
| Total Liabilities (Quarterly) | 37.91M |
| Shareholders Equity (Quarterly) | -13.29M |